LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article: Rheumatological aspects of pathogenesis and treatment of COVID-19 infection.

    Kalinova, Desislava / Rashkov, Rasho

    Reumatologia

    2020  Volume 58, Issue 4, Page(s) 231–235

    Abstract: ... with COVID-19 and those with symptomatic SARS-CoV infection and rheumatic disease. This article is an attempt ... The constantly new and tested concepts in the treatment of COVID testify to the growing knowledge about the virus ... to discuss the management of COVID-19 and coexisting rheumatic disease. ...

    Abstract Contemporary rheumatology is a field dealing with the phenomena of autoimmune states and inflammation. Rheumatic diseases cover a wide spectrum of diseases of the musculoskeletal system, connective tissue and vessels. The occurrence of an immune, autoimmune and autoinflammatory response is often linked to different kinds of infections. Which aspects of the coronavirus infection relate to rheumatological therapy and practice? In order to answer this question one needs to look at the pathogenesis of the SARS-CoV-2 infection. Antimalarial drugs may block antigen presentation of the viral peptides from antigen presenting cells, as they may alter the lysosomal proteases that mediate the viral entry in the cells and have demonstrated efficacy in improving the infection. Anti-IL-6 may interfere with cytokine storm in severe cases and use of tocilizumab has had good results in a small cohort. Baricitinib not only plays a role in inhibiting the synthesis of cytokines but it also has a function in suppressing receptor-mediated endocytosis. The constantly new and tested concepts in the treatment of COVID testify to the growing knowledge about the virus, but also to the need for more targeted therapy. Treatment regimens have been developed for both patients with COVID-19 and those with symptomatic SARS-CoV infection and rheumatic disease. This article is an attempt to discuss the management of COVID-19 and coexisting rheumatic disease.
    Keywords covid19
    Language English
    Publishing date 2020-08-31
    Publishing country Poland
    Document type Journal Article ; Review
    ZDB-ID 604151-6
    ISSN 0034-6233
    ISSN 0034-6233
    DOI 10.5114/reum.2020.98435
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Rheumatological aspects of pathogenesis and treatment of COVID-19 infection

    Desislava Kalinova / Rasho Rashkov

    Rheumatology, Vol 58, Iss 4, Pp 231-

    2020  Volume 235

    Abstract: ... with COVID-19 and those with symptomatic SARS-CoV infection and rheumatic disease. This article is an attempt ... The constantly new and tested concepts in the treatment of COVID testify to the growing knowledge about the virus ... to discuss the management of COVID-19 and coexisting rheumatic disease. ...

    Abstract Contemporary rheumatology is a field dealing with the phenomena of autoimmune states and inflammation. Rheumatic diseases cover a wide spectrum of diseases of the musculoskeletal system, connective tissue and vessels. The occurrence of an immune, autoimmune and autoinflammatory response is often linked to different kinds of infections. Which aspects of the coronavirus infection relate to rheumatological therapy and practice? In order to answer this question one needs to look at the pathogenesis of the SARS-CoV-2 infection. Antimalarial drugs may block antigen presentation of the viral peptides from antigen presenting cells, as they may alter the lysosomal proteases that mediate the viral entry in the cells and have demonstrated efficacy in improving the infection. Anti-IL-6 may interfere with cytokine storm in severe cases and use of tocilizumab has had good results in a small cohort. Baricitinib not only plays a role in inhibiting the synthesis of cytokines but it also has a function in suppressing receptor-mediated endocytosis. The constantly new and tested concepts in the treatment of COVID testify to the growing knowledge about the virus, but also to the need for more targeted therapy. Treatment regimens have been developed for both patients with COVID-19 and those with symptomatic SARS-CoV infection and rheumatic disease. This article is an attempt to discuss the management of COVID-19 and coexisting rheumatic disease.
    Keywords covid-19 infection ; anti-rheumatic drugs ; rheumatic disease ; pneumonitis ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2020-08-01T00:00:00Z
    Publisher Termedia Publishing House
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Rheumatological aspects of pathogenesis and treatment of COVID-19 infection

    Kalinova, D. / Rashkov, R.

    Reumatologia

    Abstract: ... with COVID-19 and those with symptomatic SARS-CoV infection and rheumatic disease This article is an attempt ... The constantly new and tested concepts in the treatment of COVID testify to the growing knowledge about the virus ... to discuss the management of COVID-19 and coexisting rheumatic disease ...

    Abstract Contemporary rheumatology is a field dealing with the phenomena of autoimmune states and inflammation Rheumatic diseases cover a wide spectrum of diseases of the musculoskeletal system, connective tissue and vessels The occurrence of an immune, autoimmune and autoinflammatory response is often linked to different kinds of infections Which aspects of the coronavirus infection relate to rheumatological therapy and practice? In order to answer this question one needs to look at the pathogenesis of the SARS-CoV-2 infection Antimalarial drugs may block antigen presentation of the viral peptides from antigen presenting cells, as they may alter the lysosomal proteases that mediate the viral entry in the cells and have demonstrated efficacy in improving the infection Anti-IL-6 may interfere with cytokine storm in severe cases and use of tocilizumab has had good results in a small cohort Baricitinib not only plays a role in inhibiting the synthesis of cytokines but it also has a function in suppressing receptor-mediated endocytosis The constantly new and tested concepts in the treatment of COVID testify to the growing knowledge about the virus, but also to the need for more targeted therapy Treatment regimens have been developed for both patients with COVID-19 and those with symptomatic SARS-CoV infection and rheumatic disease This article is an attempt to discuss the management of COVID-19 and coexisting rheumatic disease
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #761014
    Database COVID19

    Kategorien

To top